Barinthus Biotherapeutics BRNS
NASDAQ BRNS
$0.61 +0.01 (+1.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) EPS (Diluted) (2020 - 2026)

Barinthus Biotherapeutics (BRNS) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.23
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.33
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.19
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.15
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Barinthus Biotherapeutics 25.01 Mn 25.01 Mn - -0.26

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.26
Mar 31, 2026 -0.14
Dec 31, 2025 -0.27
Sep 30, 2025 -0.36
Jun 30, 2025 -0.52
Mar 31, 2025 -0.49
Dec 31, 2024 -0.52
Sep 30, 2024 -0.21
Jun 30, 2024 -0.43
Mar 31, 2024 -0.40
Dec 31, 2023 -0.45
Sep 30, 2023 -0.37
Jun 30, 2023 -0.62
Mar 31, 2023 -0.48
Dec 31, 2022 -0.55
Sep 30, 2022 0.22
Jun 30, 2022 0.41
Mar 31, 2022 0.07
Dec 31, 2021 -0.65
Sep 30, 2021 -0.20